{"transactions":[{"id":724993,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35035,"kind":"person","name":"Lawver Teri L","position":1,"cik":"0001960596","reported_name":"Lawver Teri L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Commercial Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:21:58.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":90000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001960596-26-000004","document":"form4-06292026_080655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000196059626000004/form4-06292026_080655.xml","form_type":"4"}},{"id":724992,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:21:16.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":93000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001838114-26-000002","document":"form4-06292026_080612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000183811426000002/form4-06292026_080612.xml","form_type":"4"}},{"id":724991,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35033,"kind":"person","name":"Young Diane C.","position":1,"cik":"0001648010","reported_name":"Young Diane C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:20:30.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":57000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001648010-26-000002","document":"form4-06292026_080627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164801026000002/form4-06292026_080627.xml","form_type":"4"}},{"id":724990,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:19:33.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":95000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001718112-26-000002","document":"form4-06292026_080629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000171811226000002/form4-06292026_080629.xml","form_type":"4"}},{"id":724989,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35031,"kind":"person","name":"Martin Samuel Bates","position":1,"cik":"0001709024","reported_name":"Martin Samuel Bates","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP AND CFO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:18:48.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":93000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001709024-26-000004","document":"form4-06292026_080644.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000170902426000004/form4-06292026_080644.xml","form_type":"4"}},{"id":724988,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35030,"kind":"person","name":"Cavanaugh Sarah","position":1,"cik":"0001709113","reported_name":"Cavanaugh Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF CORP AFFAIRS & ADMIN."}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:17:57.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":95000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001709113-26-000002","document":"form4-06292026_080653.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000170911326000002/form4-06292026_080653.xml","form_type":"4"}},{"id":724987,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35029,"kind":"person","name":"Crowley Elizabeth","position":1,"cik":"0001681854","reported_name":"Crowley Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CPDO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:17:10.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":100000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001681854-26-000002","document":"form4-06292026_080604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000168185426000002/form4-06292026_080604.xml","form_type":"4"}},{"id":724986,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35028,"kind":"person","name":"PEPIN RONALD","position":1,"cik":"0001214504","reported_name":"PEPIN RONALD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CBO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:16:10.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":20000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001214504-26-000002","document":"form4-06292026_080606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000121450426000002/form4-06292026_080606.xml","form_type":"4"}},{"id":724985,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:15:24.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":115000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001429931-26-000002","document":"form4-06292026_080620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000142993126000002/form4-06292026_080620.xml","form_type":"4"}},{"id":724984,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:14:25.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":375000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001429933-26-000002","document":"form4-06292026_080621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000142993326000002/form4-06292026_080621.xml","form_type":"4"}},{"id":724983,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35025,"kind":"person","name":"Torres Denice","position":1,"cik":"0001820278","reported_name":"Torres Denice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-29T20:12:40.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":26000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001820278-26-000008","document":"form4-06292026_080636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000182027826000008/form4-06292026_080636.xml","form_type":"4"}},{"id":724982,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":32667,"kind":"person","name":"Jain Rita","position":1,"cik":"0001707797","reported_name":"Jain Rita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-29T20:11:45.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":26000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001707797-26-000012","document":"form4-06292026_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000170779726000012/form4-06292026_080641.xml","form_type":"4"}},{"id":724981,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35024,"kind":"person","name":"NEIL GARRY ARTHUR","position":1,"cik":"0001586785","reported_name":"NEIL GARRY ARTHUR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-29T20:10:56.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":26000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001586785-26-000008","document":"form4-06292026_080652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000158678526000008/form4-06292026_080652.xml","form_type":"4"}},{"id":724980,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-29T20:10:02.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":26000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001529371-26-000005","document":"form4-06292026_080658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000152937126000005/form4-06292026_080658.xml","form_type":"4"}},{"id":724979,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35023,"kind":"person","name":"Brownlie Keith L","position":1,"cik":"0001518575","reported_name":"Brownlie Keith L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-29T20:09:16.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":26000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001518575-26-000002","document":"form4-06292026_080611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000151857526000002/form4-06292026_080611.xml","form_type":"4"}},{"id":724978,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35022,"kind":"person","name":"MARINO JAMES J","position":1,"cik":"0001198578","reported_name":"MARINO JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-29T20:08:28.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":26000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001198578-26-000002","document":"form4-06292026_080625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000119857826000002/form4-06292026_080625.xml","form_type":"4"}},{"id":724977,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-29T20:07:27.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":26000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001218815-26-000002","document":"form4-06292026_080622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000121881526000002/form4-06292026_080622.xml","form_type":"4"}},{"id":724976,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35020,"kind":"person","name":"PENNER HARRY JR","position":1,"cik":"0001131148","reported_name":"PENNER HARRY JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-29T20:06:33.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":26000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001131148-26-000002","document":"form4-06292026_080629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000113114826000002/form4-06292026_080629.xml","form_type":"4"}},{"id":949270,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35031,"kind":"person","name":"Martin Samuel Bates","position":1,"cik":"0001709024","reported_name":"Martin Samuel Bates","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP AND CFO"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-01-06T21:23:48.000Z","date":"2026-01-02","kind":"exercise","planned":false,"acquired":false,"shares":4817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As of June 18, 2024, the option is fully vested."}],"balance_after":58815,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":4817},"source":{"system":"sec-edgar","filing":"0001709024-26-000002","document":"form4-01062026_090142.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000170902426000002/form4-01062026_090142.xml","form_type":"4"}},{"id":949269,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35031,"kind":"person","name":"Martin Samuel Bates","position":1,"cik":"0001709024","reported_name":"Martin Samuel Bates","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP AND CFO"}}],"security":"Common Stock","published_at":"2026-01-06T21:23:48.000Z","date":"2026-01-02","kind":"exercise","planned":false,"acquired":true,"shares":4817,"price":10.38,"value":50000.46,"ownership":{"direct":true},"balance_after":32942,"source":{"system":"sec-edgar","filing":"0001709024-26-000002","document":"form4-01062026_090142.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000170902426000002/form4-01062026_090142.xml","form_type":"4"}},{"id":966639,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35028,"kind":"person","name":"PEPIN RONALD","position":1,"cik":"0001214504","reported_name":"PEPIN RONALD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CBO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-12-17T21:06:34.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"As of June 19, 2023, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001214504-25-000007","document":"form4-12172025_091230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000121450425000007/form4-12172025_091230.xml","form_type":"4"}},{"id":966638,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35028,"kind":"person","name":"PEPIN RONALD","position":1,"cik":"0001214504","reported_name":"PEPIN RONALD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CBO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-12-17T21:06:34.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  This option was previously reported as covering 200,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F1","text":"On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  This option was previously reported as covering 200,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of June 13, 2022, the option is fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  This option was previously reported as covering 200,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."}],"balance_after":5000,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001214504-25-000007","document":"form4-12172025_091230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000121450425000007/form4-12172025_091230.xml","form_type":"4"}},{"id":966637,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35028,"kind":"person","name":"PEPIN RONALD","position":1,"cik":"0001214504","reported_name":"PEPIN RONALD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CBO"}}],"security":"Common Stock","published_at":"2025-12-17T21:06:34.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":11000,"price":2.78,"value":30580.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 764 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan."}],"balance_after":20097,"source":{"system":"sec-edgar","filing":"0001214504-25-000007","document":"form4-12172025_091230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000121450425000007/form4-12172025_091230.xml","form_type":"4"}},{"id":966636,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35028,"kind":"person","name":"PEPIN RONALD","position":1,"cik":"0001214504","reported_name":"PEPIN RONALD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CBO"}}],"security":"Common Stock","published_at":"2025-12-17T21:06:34.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":8333,"price":9.0165,"value":75134.4945,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  This option was previously reported as covering 200,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  This option was previously reported as covering 200,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 764 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan."}],"balance_after":9097,"source":{"system":"sec-edgar","filing":"0001214504-25-000007","document":"form4-12172025_091230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000121450425000007/form4-12172025_091230.xml","form_type":"4"}},{"id":978437,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2025-12-08T21:20:35.000Z","date":"2025-12-04","kind":"sale","planned":false,"acquired":false,"shares":4166,"price":29.095,"value":121209.77,"ownership":{"direct":true},"balance_after":30796,"source":{"system":"sec-edgar","filing":"0001838114-25-000007","document":"form4-12082025_091231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000183811425000007/form4-12082025_091231.xml","form_type":"4"}},{"id":998452,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Incentive Stock Option","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":false,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% vested on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":7875,"derivative":{"exercise_price":22.48,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998451,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Incentive Stock Option","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":false,"shares":26672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of June 18, 2024, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":26672},"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998450,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Incentive Stock Option","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":false,"shares":6876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of June 13, 2022, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":6876},"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998449,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Common Stock","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":49298,"price":24.0005,"value":1183176.649,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.05 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":20833,"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998448,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Common Stock","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":true,"shares":15750,"price":22.48,"value":354060.0,"ownership":{"direct":true},"balance_after":70131,"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998447,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Common Stock","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":true,"shares":26672,"price":10.38,"value":276855.36,"ownership":{"direct":true},"balance_after":54381,"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998446,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Common Stock","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":true,"shares":6876,"price":9.0165,"value":61997.454,"ownership":{"direct":true},"balance_after":27709,"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":1003203,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35035,"kind":"person","name":"Lawver Teri L","position":1,"cik":"0001960596","reported_name":"Lawver Teri L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Commercial Officer"}}],"security":"ISO (right to buy)","published_at":"2025-11-12T21:12:27.000Z","date":"2025-11-10","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on November 10, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":100000,"derivative":{"exercise_price":22.67,"exercise_date":"2026-11-10","expiration_date":"2035-11-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001960596-25-000008","document":"form4-11122025_091122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000196059625000008/form4-11122025_091122.xml","form_type":"4"}},{"id":1065954,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2025-08-15T20:07:28.000Z","date":"2025-08-13","kind":"sale","planned":false,"acquired":false,"shares":430,"price":25.415,"value":10928.45,"ownership":{"direct":true},"balance_after":34962,"source":{"system":"sec-edgar","filing":"0001415889-25-022069","document":"form4-08152025_080825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925022069/form4-08152025_080825.xml","form_type":"4"}},{"id":1065953,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2025-08-15T20:07:28.000Z","date":"2025-08-13","kind":"sale","planned":false,"acquired":false,"shares":341,"price":23.9515,"value":8167.4615,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 269 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan."}],"balance_after":35392,"source":{"system":"sec-edgar","filing":"0001415889-25-022069","document":"form4-08152025_080825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925022069/form4-08152025_080825.xml","form_type":"4"}},{"id":1119017,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35030,"kind":"person","name":"Cavanaugh Sarah","position":1,"cik":"0001709113","reported_name":"Cavanaugh Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF CORP AFFAIRS & ADMIN."}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:22:56.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":78000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001415889-25-016260","document":"form4-06092025_080647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016260/form4-06092025_080647.xml","form_type":"4"}},{"id":1119016,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35029,"kind":"person","name":"Crowley Elizabeth","position":1,"cik":"0001681854","reported_name":"Crowley Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CPDO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:22:10.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":85000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001415889-25-016257","document":"form4-06092025_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016257/form4-06092025_080605.xml","form_type":"4"}},{"id":1119015,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:21:03.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":82000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":82000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":82000},"source":{"system":"sec-edgar","filing":"0001415889-25-016255","document":"form4-06092025_080648.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016255/form4-06092025_080648.xml","form_type":"4"}},{"id":1119014,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:18:04.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":75000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-25-016244","document":"form4-06092025_080659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016244/form4-06092025_080659.xml","form_type":"4"}},{"id":1119013,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35031,"kind":"person","name":"Martin Samuel Bates","position":1,"cik":"0001709024","reported_name":"Martin Samuel Bates","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP AND CFO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:17:18.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":81000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001415889-25-016242","document":"form4-06092025_080614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016242/form4-06092025_080614.xml","form_type":"4"}},{"id":1119011,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35028,"kind":"person","name":"PEPIN RONALD","position":1,"cik":"0001214504","reported_name":"PEPIN RONALD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CBO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:16:15.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":20000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-016241","document":"form4-06092025_080610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016241/form4-06092025_080610.xml","form_type":"4"}},{"id":1119012,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35033,"kind":"person","name":"Young Diane C.","position":1,"cik":"0001648010","reported_name":"Young Diane C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:15:34.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":72000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001415889-25-016238","document":"form4-06092025_080613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016238/form4-06092025_080613.xml","form_type":"4"}},{"id":1119009,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:14:28.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":93000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001415889-25-016230","document":"form4-06092025_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016230/form4-06092025_080623.xml","form_type":"4"}},{"id":1119010,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:13:34.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":300000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-25-016227","document":"form4-06092025_080629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016227/form4-06092025_080629.xml","form_type":"4"}},{"id":1119008,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35025,"kind":"person","name":"Torres Denice","position":1,"cik":"0001820278","reported_name":"Torres Denice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-09T20:12:53.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Such option vests in three equal annual installments beginning June 5, 2026."}],"balance_after":33000,"derivative":{"exercise_price":19.53,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001415889-25-016226","document":"form4-06092025_080642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016226/form4-06092025_080642.xml","form_type":"4"}},{"id":1119007,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":32667,"kind":"person","name":"Jain Rita","position":1,"cik":"0001707797","reported_name":"Jain Rita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-09T20:10:54.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-25-016225","document":"form4-06092025_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016225/form4-06092025_080641.xml","form_type":"4"}},{"id":1119006,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35024,"kind":"person","name":"NEIL GARRY ARTHUR","position":1,"cik":"0001586785","reported_name":"NEIL GARRY ARTHUR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-09T20:10:02.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-25-016222","document":"form4-06092025_080657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016222/form4-06092025_080657.xml","form_type":"4"}},{"id":1119005,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35020,"kind":"person","name":"PENNER HARRY JR","position":1,"cik":"0001131148","reported_name":"PENNER HARRY JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-09T20:09:08.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-25-016220","document":"form4-06092025_080604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016220/form4-06092025_080604.xml","form_type":"4"}},{"id":1119004,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-09T20:08:36.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-25-016219","document":"form4-06092025_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016219/form4-06092025_080631.xml","form_type":"4"}},{"id":1119003,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35022,"kind":"person","name":"MARINO JAMES J","position":1,"cik":"0001198578","reported_name":"MARINO JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-09T20:07:52.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-25-016217","document":"form4-06092025_080645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016217/form4-06092025_080645.xml","form_type":"4"}},{"id":1119002,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35023,"kind":"person","name":"Brownlie Keith L","position":1,"cik":"0001518575","reported_name":"Brownlie Keith L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-09T20:07:08.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-25-016216","document":"form4-06092025_080604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016216/form4-06092025_080604.xml","form_type":"4"}},{"id":1119001,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-09T20:06:11.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-25-016215","document":"form4-06092025_080601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016215/form4-06092025_080601.xml","form_type":"4"}},{"id":1357989,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35022,"kind":"person","name":"MARINO JAMES J","position":1,"cik":"0001198578","reported_name":"MARINO JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-20T21:02:46.000Z","date":"2024-11-18","kind":"gift","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents a gift transfer to an immediate family member of the reporting person who does not share the same household as the reporting person."}],"balance_after":2204,"source":{"system":"sec-edgar","filing":"0001415889-24-027329","document":"form4-11202024_091142.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924027329/form4-11202024_091142.xml","form_type":"4"}},{"id":1370401,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2024-11-12T13:01:10.000Z","date":"2024-11-11","kind":"purchase","planned":false,"acquired":true,"shares":11500,"price":26.82,"value":308430.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,092 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan."}],"balance_after":40284,"source":{"system":"sec-edgar","filing":"0001415889-24-026489","document":"form4-11122024_011107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924026489/form4-11122024_011107.xml","form_type":"4"}},{"id":1476645,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35031,"kind":"person","name":"Martin Samuel Bates","position":1,"cik":"0001709024","reported_name":"Martin Samuel Bates","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP AND CFO"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-18T20:05:20.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":false,"shares":16968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of June 18, 2024, the option is fully vested."}],"balance_after":63632,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":16968},"source":{"system":"sec-edgar","filing":"0001415889-24-017363","document":"form4-06182024_080610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017363/form4-06182024_080610.xml","form_type":"4"}},{"id":1476644,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35031,"kind":"person","name":"Martin Samuel Bates","position":1,"cik":"0001709024","reported_name":"Martin Samuel Bates","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP AND CFO"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-18T20:05:20.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":false,"shares":3201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of June 13, 2022, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":3201},"source":{"system":"sec-edgar","filing":"0001415889-24-017363","document":"form4-06182024_080610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017363/form4-06182024_080610.xml","form_type":"4"}},{"id":1476643,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35031,"kind":"person","name":"Martin Samuel Bates","position":1,"cik":"0001709024","reported_name":"Martin Samuel Bates","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP AND CFO"}}],"security":"Common Stock","published_at":"2024-06-18T20:05:20.000Z","date":"2024-06-14","kind":"sale","planned":false,"acquired":false,"shares":17172,"price":35.4248,"value":608314.6656,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.89 to $35.76 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":28125,"source":{"system":"sec-edgar","filing":"0001415889-24-017363","document":"form4-06182024_080610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017363/form4-06182024_080610.xml","form_type":"4"}},{"id":1476642,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35031,"kind":"person","name":"Martin Samuel Bates","position":1,"cik":"0001709024","reported_name":"Martin Samuel Bates","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP AND CFO"}}],"security":"Common Stock","published_at":"2024-06-18T20:05:20.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":true,"shares":16968,"price":10.38,"value":176127.84,"ownership":{"direct":true},"balance_after":45297,"source":{"system":"sec-edgar","filing":"0001415889-24-017363","document":"form4-06182024_080610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017363/form4-06182024_080610.xml","form_type":"4"}},{"id":1476641,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35031,"kind":"person","name":"Martin Samuel Bates","position":1,"cik":"0001709024","reported_name":"Martin Samuel Bates","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP AND CFO"}}],"security":"Common Stock","published_at":"2024-06-18T20:05:20.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":true,"shares":3201,"price":9.0165,"value":28861.8165,"ownership":{"direct":true},"balance_after":28329,"source":{"system":"sec-edgar","filing":"0001415889-24-017363","document":"form4-06182024_080610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017363/form4-06182024_080610.xml","form_type":"4"}},{"id":1476640,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35029,"kind":"person","name":"Crowley Elizabeth","position":1,"cik":"0001681854","reported_name":"Crowley Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CPDO"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-18T20:04:13.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of June 18, 2024, the option is fully vested."}],"balance_after":46500,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-24-017362","document":"form4-06182024_080610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017362/form4-06182024_080610.xml","form_type":"4"}},{"id":1476639,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35029,"kind":"person","name":"Crowley Elizabeth","position":1,"cik":"0001681854","reported_name":"Crowley Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CPDO"}}],"security":"Common Stock","published_at":"2024-06-18T20:04:13.000Z","date":"2024-06-14","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":34.8654,"value":1045962.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.51 to $35.39 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":9074,"source":{"system":"sec-edgar","filing":"0001415889-24-017362","document":"form4-06182024_080610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017362/form4-06182024_080610.xml","form_type":"4"}},{"id":1476638,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35029,"kind":"person","name":"Crowley Elizabeth","position":1,"cik":"0001681854","reported_name":"Crowley Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CPDO"}}],"security":"Common Stock","published_at":"2024-06-18T20:04:13.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":10.38,"value":311400.0,"ownership":{"direct":true},"balance_after":39074,"source":{"system":"sec-edgar","filing":"0001415889-24-017362","document":"form4-06182024_080610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017362/form4-06182024_080610.xml","form_type":"4"}},{"id":1478185,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:19:47.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":75000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-24-017190","document":"form4-06172024_080643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017190/form4-06172024_080643.xml","form_type":"4"}},{"id":1478184,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35033,"kind":"person","name":"Young Diane C.","position":1,"cik":"0001648010","reported_name":"Young Diane C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:18:38.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":72000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001415889-24-017186","document":"form4-06172024_080635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017186/form4-06172024_080635.xml","form_type":"4"}},{"id":1478183,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:17:58.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":82000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":82000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":82000},"source":{"system":"sec-edgar","filing":"0001415889-24-017184","document":"form4-06172024_080655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017184/form4-06172024_080655.xml","form_type":"4"}},{"id":1478182,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35030,"kind":"person","name":"Cavanaugh Sarah","position":1,"cik":"0001709113","reported_name":"Cavanaugh Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF CORP AFFAIRS & ADMIN."}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:17:23.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":78000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001415889-24-017182","document":"form4-06172024_080619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017182/form4-06172024_080619.xml","form_type":"4"}},{"id":1478181,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35029,"kind":"person","name":"Crowley Elizabeth","position":1,"cik":"0001681854","reported_name":"Crowley Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CPDO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:16:41.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":85000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001415889-24-017179","document":"form4-06172024_080638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017179/form4-06172024_080638.xml","form_type":"4"}},{"id":1478180,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:16:12.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":65000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001415889-24-017177","document":"form4-06172024_080608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017177/form4-06172024_080608.xml","form_type":"4"}},{"id":1478179,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35028,"kind":"person","name":"PEPIN RONALD","position":1,"cik":"0001214504","reported_name":"PEPIN RONALD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CBO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:15:43.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":20000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-017175","document":"form4-06172024_080640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017175/form4-06172024_080640.xml","form_type":"4"}},{"id":1478178,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35031,"kind":"person","name":"Martin Samuel Bates","position":1,"cik":"0001709024","reported_name":"Martin Samuel Bates","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP AND CFO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:13:57.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":81000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001415889-24-017163","document":"form4-06172024_080654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017163/form4-06172024_080654.xml","form_type":"4"}},{"id":1478177,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:13:19.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":93000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001415889-24-017161","document":"form4-06172024_080615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017161/form4-06172024_080615.xml","form_type":"4"}},{"id":1478176,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:12:26.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":300000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-24-017159","document":"form4-06172024_080622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017159/form4-06172024_080622.xml","form_type":"4"}},{"id":1478175,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":32667,"kind":"person","name":"Jain Rita","position":1,"cik":"0001707797","reported_name":"Jain Rita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:11:44.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-24-017158","document":"form4-06172024_080640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017158/form4-06172024_080640.xml","form_type":"4"}},{"id":1478174,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35024,"kind":"person","name":"NEIL GARRY ARTHUR","position":1,"cik":"0001586785","reported_name":"NEIL GARRY ARTHUR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:10:54.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-24-017155","document":"form4-06172024_080651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017155/form4-06172024_080651.xml","form_type":"4"}},{"id":1478173,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:10:24.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-24-017153","document":"form4-06172024_080620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017153/form4-06172024_080620.xml","form_type":"4"}},{"id":1478172,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35023,"kind":"person","name":"Brownlie Keith L","position":1,"cik":"0001518575","reported_name":"Brownlie Keith L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:08:46.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-24-017151","document":"form4-06172024_080643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017151/form4-06172024_080643.xml","form_type":"4"}},{"id":1478171,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35022,"kind":"person","name":"MARINO JAMES J","position":1,"cik":"0001198578","reported_name":"MARINO JAMES J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:04:25.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-24-017141","document":"form4-06172024_080622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017141/form4-06172024_080622.xml","form_type":"4"}},{"id":1478170,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35021,"kind":"person","name":"CONRAD HERBERT J","position":1,"cik":"0001218815","reported_name":"CONRAD HERBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:03:51.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-24-017140","document":"form4-06172024_080647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017140/form4-06172024_080647.xml","form_type":"4"}},{"id":1478169,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":89857,"kind":"person","name":"Shoos Karen L.","position":1,"cik":"0001255681","reported_name":"Shoos Karen L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:03:18.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-24-017138","document":"form4-06172024_080614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017138/form4-06172024_080614.xml","form_type":"4"}},{"id":1478168,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35020,"kind":"person","name":"PENNER HARRY JR","position":1,"cik":"0001131148","reported_name":"PENNER HARRY JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:02:42.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-24-017137","document":"form4-06172024_080638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017137/form4-06172024_080638.xml","form_type":"4"}},{"id":1481524,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35033,"kind":"person","name":"Young Diane C.","position":1,"cik":"0001648010","reported_name":"Young Diane C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Incentive Stock Option","published_at":"2024-06-13T20:05:23.000Z","date":"2024-06-11","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As of July 8, 2023, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.71,"expiration_date":"2029-07-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-24-016651","document":"form4-06132024_080617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924016651/form4-06132024_080617.xml","form_type":"4"}},{"id":1481523,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35033,"kind":"person","name":"Young Diane C.","position":1,"cik":"0001648010","reported_name":"Young Diane C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-13T20:05:23.000Z","date":"2024-06-11","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":2.71,"value":40650.0,"ownership":{"direct":true},"balance_after":17115,"source":{"system":"sec-edgar","filing":"0001415889-24-016651","document":"form4-06132024_080617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924016651/form4-06132024_080617.xml","form_type":"4"}},{"id":1484272,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35029,"kind":"person","name":"Crowley Elizabeth","position":1,"cik":"0001681854","reported_name":"Crowley Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CPDO"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-11T20:02:57.000Z","date":"2024-06-07","kind":"exercise","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of June 13, 2022, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001415889-24-016345","document":"form4-06112024_080653.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924016345/form4-06112024_080653.xml","form_type":"4"}},{"id":1484271,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35029,"kind":"person","name":"Crowley Elizabeth","position":1,"cik":"0001681854","reported_name":"Crowley Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CPDO"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-11T20:02:57.000Z","date":"2024-06-07","kind":"exercise","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":76500,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001415889-24-016345","document":"form4-06112024_080653.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924016345/form4-06112024_080653.xml","form_type":"4"}},{"id":1484270,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35029,"kind":"person","name":"Crowley Elizabeth","position":1,"cik":"0001681854","reported_name":"Crowley Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CPDO"}}],"security":"Common Stock","published_at":"2024-06-11T20:02:57.000Z","date":"2024-06-07","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":35.0582,"value":525873.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.86 to $35.59 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":9074,"source":{"system":"sec-edgar","filing":"0001415889-24-016345","document":"form4-06112024_080653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924016345/form4-06112024_080653.xml","form_type":"4"}},{"id":1484269,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35029,"kind":"person","name":"Crowley Elizabeth","position":1,"cik":"0001681854","reported_name":"Crowley Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CPDO"}}],"security":"Common Stock","published_at":"2024-06-11T20:02:57.000Z","date":"2024-06-07","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":9.0165,"value":67623.75,"ownership":{"direct":true},"balance_after":24074,"source":{"system":"sec-edgar","filing":"0001415889-24-016345","document":"form4-06112024_080653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924016345/form4-06112024_080653.xml","form_type":"4"}},{"id":1484268,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35029,"kind":"person","name":"Crowley Elizabeth","position":1,"cik":"0001681854","reported_name":"Crowley Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CPDO"}}],"security":"Common Stock","published_at":"2024-06-11T20:02:57.000Z","date":"2024-06-07","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":10.38,"value":77850.0,"ownership":{"direct":true},"balance_after":16574,"source":{"system":"sec-edgar","filing":"0001415889-24-016345","document":"form4-06112024_080653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924016345/form4-06112024_080653.xml","form_type":"4"}},{"id":1484267,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35033,"kind":"person","name":"Young Diane C.","position":1,"cik":"0001648010","reported_name":"Young Diane C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-11T20:01:54.000Z","date":"2024-06-07","kind":"sale","planned":false,"acquired":false,"shares":45000,"price":35.2632,"value":1586844.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.67 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":2115,"source":{"system":"sec-edgar","filing":"0001415889-24-016344","document":"form4-06112024_080650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924016344/form4-06112024_080650.xml","form_type":"4"}},{"id":1487816,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-07T20:05:16.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":false,"shares":9540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":18454,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":9540},"source":{"system":"sec-edgar","filing":"0001415889-24-015950","document":"form4-06072024_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015950/form4-06072024_080609.xml","form_type":"4"}},{"id":1487815,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35034,"kind":"person","name":"Jimenez Freddy A.","position":1,"cik":"0001838114","reported_name":"Jimenez Freddy A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2024-06-07T20:05:16.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":true,"shares":9540,"price":10.38,"value":99025.2,"ownership":{"direct":true},"balance_after":35464,"source":{"system":"sec-edgar","filing":"0001415889-24-015950","document":"form4-06072024_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015950/form4-06072024_080609.xml","form_type":"4"}},{"id":1491055,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-05T20:06:42.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":58369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":23023,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":58369},"source":{"system":"sec-edgar","filing":"0001415889-24-015544","document":"form4-06052024_080636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015544/form4-06052024_080636.xml","form_type":"4"}},{"id":1491054,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-05T20:06:42.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":6289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of June 13, 2022, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":6289},"source":{"system":"sec-edgar","filing":"0001415889-24-015544","document":"form4-06052024_080636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015544/form4-06052024_080636.xml","form_type":"4"}},{"id":1491053,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Common Stock","published_at":"2024-06-05T20:06:42.000Z","date":"2024-06-03","kind":"sale","planned":false,"acquired":false,"shares":58369,"price":33.6495,"value":1964087.6655,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.27 to $34.08 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.27 to $34.08 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.27 to $34.08 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":13383,"source":{"system":"sec-edgar","filing":"0001415889-24-015544","document":"form4-06052024_080636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015544/form4-06052024_080636.xml","form_type":"4"}},{"id":1491052,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Common Stock","published_at":"2024-06-05T20:06:42.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":true,"shares":58369,"price":10.38,"value":605870.22,"ownership":{"direct":true},"balance_after":71752,"source":{"system":"sec-edgar","filing":"0001415889-24-015544","document":"form4-06052024_080636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015544/form4-06052024_080636.xml","form_type":"4"}},{"id":1491051,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Common Stock","published_at":"2024-06-05T20:06:42.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":true,"shares":6289,"price":9.0165,"value":56704.7685,"ownership":{"direct":true},"balance_after":13383,"source":{"system":"sec-edgar","filing":"0001415889-24-015544","document":"form4-06052024_080636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015544/form4-06052024_080636.xml","form_type":"4"}},{"id":1491048,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":18375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% vested on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":23625,"derivative":{"exercise_price":22.48,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":18375},"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1491047,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":28469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% vested on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":13531,"derivative":{"exercise_price":28,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":28469},"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1491046,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":20625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of June 19, 2023, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":20625},"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1491045,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Common Stock","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"sale","planned":false,"acquired":false,"shares":19264,"price":33.9854,"value":654694.7456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.815 to $34.20 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.815 to $34.20 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.815 to $34.20 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":20833,"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1491044,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Common Stock","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"sale","planned":false,"acquired":false,"shares":27580,"price":33.5264,"value":924658.112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.81 to $33.81 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.81 to $33.81 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.81 to $33.81 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":40097,"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}}],"next_cursor":"2024-06-05T20:05:45.000000Z,1491044"}